These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10503561)

  • 1. Plasma noradrenaline and neuropeptide-Y may not be of primary importance in the pathophysiology of cardiac involvement in systemic sclerosis.
    Kazzam E; Caidahl K; Hedner T; Hedner J; Waldenström A
    Scand J Rheumatol; 1999; 28(4):238-43. PubMed ID: 10503561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure.
    Feng QP; Hedner T; Andersson B; Lundberg JM; Waagstein F
    Br Heart J; 1994 Mar; 71(3):261-7. PubMed ID: 8142196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma neuropeptide Y immunoreactivity influences left ventricular mass in pheochromocytoma.
    Kuch-Wocial A; Slubowska K; Kostrubiec M; Pasierski T; Januszewicz W; Switalska H; Wocial B; Pruszczyk P
    Clin Chim Acta; 2004 Jul; 345(1-2):43-7. PubMed ID: 15193976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease.
    Zoccali C; Mallamaci F; Tripepi G; Benedetto FA; Parlongo S; Cutrupi S; Bonanno G; Rapisarda F; Fatuzzo P; Seminara G; Cataliotti A; Malatino LS
    J Hypertens; 2003 Jul; 21(7):1355-62. PubMed ID: 12817184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac outflow of endothelin, neuropeptide Y and noradrenaline in relation to hyperaemia in coronary sinus flow following electrical conversion of induced ventricular fibrillation in man.
    Runsiö M; Rosenqvist M; Bergfeldt L; Owall A; Lundberg JM; Franco-Cereceda A
    Eur Heart J; 1995 Dec; 16(12):1925-9. PubMed ID: 8682028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y-like immunoreactivity and hypertension.
    Erlinge D; Ekman R; Thulin T; Edvinsson L
    J Hypertens; 1992 Oct; 10(10):1221-5. PubMed ID: 1335004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man.
    Morris MJ; Russell AE; Kapoor V; Cain MD; Elliott JM; West MJ; Wing LM; Chalmers JP
    J Auton Nerv Syst; 1986 Oct; 17(2):143-9. PubMed ID: 3782722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y, noradrenaline and invasive haemodynamic data in mild to moderate chronic congestive heart failure.
    Ullman B; Jensen-Urstad M; Hulting J; Lundberg JM
    Clin Physiol; 1993 Jul; 13(4):409-18. PubMed ID: 8370239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of plasma neuropeptide Y-like immunoreactivity and noradrenaline during myocardial ischaemia in man.
    Ullman B; Franco-Cereceda A; Hulting J; Lundberg JM; Sollevi A
    J Intern Med; 1990 Dec; 228(6):583-9. PubMed ID: 2280235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial plasma noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years.
    Strand AH; Gudmundsdottir H; Os I; Smith G; Westheim AS; Bjørnerheim R; Kjeldsen SE
    J Hypertens; 2006 May; 24(5):905-13. PubMed ID: 16612253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine-induced release of noradrenaline and neuropeptide Y in guinea pig heart.
    Richardt G; Haass M; Neeb S; Hock M; Lang RE; Schömig A
    Klin Wochenschr; 1988; 66 Suppl 11():21-7. PubMed ID: 3184776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related changes of exercise-induced plasma catecholamines and neuropeptide Y responses in normal human subjects.
    Winther Jensen E; Espersen K; Kanstrup IL; Christensen NJ
    Acta Physiol Scand; 1992 Feb; 144(2):129-33. PubMed ID: 1575046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic peptide and its relation to cardiac dimensions and function in patients with systemic sclerosis.
    Kazzam E; Caidahl K; Hedner T; Hedner J; Hällgren R; Waldenström A
    Presse Med; 1994 Mar; 23(12):565-70. PubMed ID: 8066058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarette smoke-induced elevation of plasma neuropeptide Y levels in man.
    Rudehill A; Franco-Cereceda A; Hemsén A; Stensdotter M; Pernow J; Lundberg JM
    Clin Physiol; 1989 Jun; 9(3):243-8. PubMed ID: 2743742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of neuropeptide Y and noradrenaline from the human heart after aortic occlusion during coronary artery surgery.
    Franco-Cereceda A; Owall A; Settergren G; Sollevi A; Lundberg JM
    Cardiovasc Res; 1990 Mar; 24(3):242-6. PubMed ID: 2346958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans.
    Morris MJ; Cox HS; Lambert GW; Kaye DM; Jennings GL; Meredith IT; Esler MD
    Hypertension; 1997 Jan; 29(1 Pt 1):137-43. PubMed ID: 9039093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin may be pathogenic in systemic sclerosis of the heart.
    Kazzam E; Waldenström A; Hedner T; Hedner J; Caidahl K
    Int J Cardiol; 1997 Jun; 60(1):31-9. PubMed ID: 9209937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of neuropeptide Y upon haemorrhagic hypovolaemia in relation to vasoconstrictor effects in the pig.
    Rudehill A; Olcén M; Sollevi A; Hamberger B; Lundberg JM
    Acta Physiol Scand; 1987 Dec; 131(4):517-23. PubMed ID: 3442241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography: relationship with neurohormonal activation and endothelial dysfunction.
    Dimitroulas T; Giannakoulas G; Papadopoulou K; Karvounis H; Dimitroula H; Koliakos G; Karamitsos T; Parcharidou D; Settas L
    J Rheumatol; 2010 May; 37(5):993-9. PubMed ID: 20194451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between left ventricular deformation and heart rate variability in patients with systemic sclerosis: Two- and three-dimensional strain analysis.
    Tadic M; Zlatanovic M; Cuspidi C; Ivanovic B; Stevanovic A; Damjanov N; Kocijancic V; Celic V
    Int J Cardiol; 2017 Jun; 236():145-150. PubMed ID: 28222894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.